ADENOASSOCIATED VIRUS 2-MEDIATED HIGH-EFFICIENCY GENE-TRANSFER INTO IMMATURE AND MATURE SUBSETS OF HEMATOPOIETIC PROGENITOR CELLS IN HUMAN UMBILICAL-CORD BLOOD

被引:116
作者
ZHOU, SZ
COOPER, S
KANG, LY
RUGGIERI, L
HEIMFELD, S
SRIVASTAVA, A
BROXMEYER, HE
机构
[1] INDIANA UNIV, SCH MED, WALTHER ONCOL CTR, INDIANAPOLIS, IN 46202 USA
[2] INDIANA UNIV, SCH MED, DEPT MED, DIV HEMATOL ONCOL, INDIANAPOLIS, IN 46202 USA
[3] INDIANA UNIV, SCH MED, DEPT MICROBIOL & IMMUNOL, INDIANAPOLIS, IN 46202 USA
[4] CELLPRO INC, BOTHELL, WA 98021 USA
关键词
D O I
10.1084/jem.179.6.1867
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recombinant adeno-associated virus 2 (AAV) virions were constructed containing a gene for resistance to neomycin (neo(R)), under the control of either the herpesvirus thymidine kinase (TK) gene promoter (vTK-Neo), or the human parvovirus B19 p6 promoter (vB19-Neo), as well as those containing an upstream erythroid cell-specific enhancer (HS-2) from the locus control region of the human beta-globin gene cluster (vHS2-TK-Neo; vHS2-B19-Neo). These recombinant virions were used to infect either low density or highly enriched populations of CD34(+) cells isolated from human umbilical cord blood. In clonogenic assays initiated with cells infected with the different recombinant AAV-Neo virions, equivalent high frequency transduction of the neo(R) gene into slow-cycling multipotential, erythroid, and granulocyte/macrophage (GM) progenitor cells, including those with high proliferative potential, was obtained without prestimulation with growth factors, indicating that these immature and mature hematopoietic progenitor cells were susceptible to infection by the recombinant AAV virions. Successful transduction did not require and was not enhanced by prestimulation of these cell populations with cytokines. The functional activity of the transduced neo gene was evident by the development of resistance to the drug G418, a neomycin analogue. Individual high and low proliferative colony-forming unit (CFU)-GM, burst-forming unit-erythroid, and CFU-granulocyte erythroid macrophage megakaryocyte colonies from mock-infected, or the recombinant virus-infected cultures were subjected to polymerase chain reaction analysis using a neo-specific synthetic oligonucleotide primer pair. A 276-bp DNA fragment that hybridized with a neo-specific DNA probe on Southern blots was only detected in those colonies cloned from the recombinant virus-infected cells, indicating stable integration of the transduced neo gene. These studies suggest that parvovirus-based vectors may prove to be a useful alternative to the more commonly used retroviral vectors for high efficiency gene transfer into slow or noncycling primitive hematopoietic progenitor cells, without the need for growth factor stimulation, which could potentially lead to differentiation of these cells before transplantation.
引用
收藏
页码:1867 / 1875
页数:9
相关论文
共 69 条
[11]   RELEASE FROM QUIESCENCE OF CD34+ CD38- HUMAN UMBILICAL-CORD BLOOD-CELLS REVEALS THEIR POTENTIALITY TO ENGRAFT ADULTS [J].
CARDOSO, AA ;
LI, ML ;
BATARD, P ;
HATZFELD, A ;
BROWN, EL ;
LEVESQUE, JP ;
SOOKDEO, H ;
PANTERNE, B ;
SANSILVESTRI, P ;
CLARK, SC ;
HATZFELD, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8707-8711
[12]  
CAROW CE, 1993, BLOOD, V81, P942
[13]  
Carter Barrie J., 1992, Current Opinion in Biotechnology, V3, P533, DOI 10.1016/0958-1669(92)90082-T
[14]   DUAL-TARGET INHIBITION OF HIV-1 INVITRO BY MEANS OF AN ADENOASSOCIATED VIRUS ANTISENSE VECTOR [J].
CHATTERJEE, S ;
JOHNSON, PR ;
WONG, KK .
SCIENCE, 1992, 258 (5087) :1485-1488
[15]   CHARACTERIZATION AND MOLECULAR-CLONING OF A HUMAN PARVOVIRUS GENOME [J].
COTMORE, SF ;
TATTERSALL, P .
SCIENCE, 1984, 226 (4679) :1161-1165
[16]   THE AUTONOMOUSLY REPLICATING PARVOVIRUSES OF VERTEBRATES [J].
COTMORE, SF ;
TATTERSALL, P .
ADVANCES IN VIRUS RESEARCH, 1987, 33 :91-174
[17]   EFFECT OF ADENO-ASSOCIATED VIRUS ON CANCER EXPRESSION BY HERPES-VIRUS-TRANSFORMED HAMSTER CELLS [J].
CUKOR, G ;
BLACKLOW, NR ;
KIBRICK, S ;
SWAN, IC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (04) :957-959
[18]   HELPER VIRUS-INDUCED T-CELL LYMPHOMA IN NONHUMAN-PRIMATES AFTER RETROVIRAL MEDIATED GENE-TRANSFER [J].
DONAHUE, RE ;
KESSLER, SW ;
BODINE, D ;
MCDONAGH, K ;
DUNBAR, C ;
GOODMAN, S ;
AGRICOLA, B ;
BYRNE, E ;
RAFFELD, M ;
MOEN, R ;
BACHER, J ;
ZSEBO, KM ;
NIENHUIS, AW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1125-1135
[19]   PERSISTENT B19 PARVOVIRUS INFECTION IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) - A TREATABLE CAUSE OF ANEMIA IN AIDS [J].
FRICKHOFEN, N ;
ABKOWITZ, JL ;
SAFFORD, M ;
BERRY, JM ;
ANTUNEZDEMAYOLO, J ;
ASTROW, A ;
COHEN, R ;
HALPERIN, I ;
KING, L ;
MINTZER, D ;
COHEN, B ;
YOUNG, NS .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (12) :926-933
[20]   HEMATOPOIETIC RECONSTITUTION IN A PATIENT WITH FANCONIS ANEMIA BY MEANS OF UMBILICAL-CORD BLOOD FROM AN HLA-IDENTICAL SIBLING [J].
GLUCKMAN, E ;
BROXMEYER, HE ;
AUERBACH, AD ;
FRIEDMAN, HS ;
DOUGLAS, GW ;
DEVERGIE, A ;
ESPEROU, H ;
THIERRY, D ;
SOCIE, G ;
LEHN, P ;
COOPER, S ;
ENGLISH, D ;
KURTZBERG, J ;
BARD, J ;
BOYSE, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (17) :1174-1178